Dimension Therapeutics announced the successful completion of a Series B financing totaling $65 million Read the full story

Minerva Neurosciences will raise approximately $31 million of gross proceeds in a private placement offering to several institutional investors Read the full story

BioScrip announced the sale of $62.5 million in Series A Convertible Preferred Stock to Coliseum Capital Management and affiliated funds.

The Preferred Stock is convertible into 12,088,975 shares of BioScrip's common stock at a conversion price of $5.17 per share Read the full story

Amarin has entered into a definitive securities subscription agreement with a group of institutional investors Read the full story

Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging Read the full story

Tricida announced the closing of a $30M Series B financing Read the full story

Spring Bank Pharmaceuticals announced the closing of a $22 million financing Read the full story

Lyric Pharmaceuticals announced the initial closing of a Series A financing round totaling $20.4 million Read the full story